Peloton Interactive Inc. Stock Slides 3.9%, Underperforms Peers
Dow Jones2026/10/21 20:35This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Peloton Interactive Inc. shed 3.9% to $5.24 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.1% to 26,702.86 and the Dow Jones Industrial Average rising 0.7% to 52,856.09.
The stock's fall snapped a two-day winning streak.
Peloton Interactive Inc. closed 36.0% below its 52-week high of $8.19, which the company reached on October 22nd.
The stock underperformed when compared to some of its peers, as Apple Inc. rose 1.3% to $343.99, Nike Inc. Cl B fell 0.9% to $37.53, and lululemon athletica inc. fell 3.41% to $96.53.
Trading volume totaled 4.4 million, compared to the 50-day average of 8.4 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 21, 2026 16:35 ET (20:35 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Rocket Lab’s stock falls as quarterly loss exceeds expectations
BUZZ-Take-Two shares rise after raising annual revenue and profit forecasts
Itaúsa Q3 2026 recurring net profit rises 25% to R$ 5.06 billion year-on-year
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
Crypto prices
More
